Multiple Sclerosis Plasma
About: Multiple Sclerosis Plasma - Cryopreserved human plasma collected from clinically confirmed multiple sclerosis (MS) donors. Multiple Sclerosis Plasma is ideal for studying soluble biomarkers to understand disease activity, inflammation, and neurodegeneration. Bulk plasma is available.
| Lot # | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 74781 | Multiple Sclerosis | 1.0 ML | Asian/Pacific Islander | 31 | Male | United States (US) |
No medications
|
6 | $316.00 | |
| 72917 | Multiple Sclerosis | 1.0 ML | Caucasian | 50 | Male | United States (US) |
Ocrevus 600mg - infusion twice a year Aricept 10mg QD Baclofen 30mg BID Trospium chloride 20mg BID Cymbalta 60mg QD
|
6 | $316.00 | |
| 67689 | Multiple Sclerosis | 1.0 ML | Caucasian | 60 | Female | United States (US) |
tizanidine 6mg qid baclofen 20mg qid Ritalin 10mg tid zyrtec daily coreg 6.25mg 2x/d gabapentin 2200mg/d (divided up) tylenol PRN vitamin d 2000 UD QD calcium 1200 mg QD
|
19 | $316.00 | |
| 67899 | Multiple Sclerosis | 1.0 ML | Caucasian | 54 | Female | United States (US) |
6/17/25- Ocrevus twice a year. Modafanil 2x daily 200mg. Rosuvastatin 10 mg daily. VitaminD 50000 units weekly. Magnesium. Ozempic 50 mg a week. Metformin 1000mg daily. . tysabri QM Injection modafanil 200mg BID Vitamin D QD Iron supplement QD B12 gabapentin QD
|
13 | $316.00 | |
| 67521 | Multiple Sclerosis | 1.0 ML | Caucasian | 37 | Female | United States (US) |
6/18/25- Kesimpta (once a month), fluoxetine 40 mg, synthroid 50 mcg, beyaz, 4AP, magnesium oxidize Tysabri IV Q28Days Prozac 40 mg po QD Synthroid 50mcg Gabapentin 200mg PRN
|
16 | $316.00 | |
| 67723 | Multiple Sclerosis | 1.0 ML | Caucasian | 48 | Female | United States (US) |
Tecfidera 240 mg po BID Effexor 75 mg po QD Vit D 2000 IU's po QD Botox inj Q3M
|
9 | $316.00 | |
| 67794 | Multiple Sclerosis | 1.0 ML | Caucasian | 60 | Female | United States (US) |
6/18/25- Avonex 30 ug IM, benazepril 40 Mg, omeprazole 10 mg ?Crestor 10 mg, Vitamin D 2000u , Celexa 40 mg, Ambien 10 mg, alprazolam .25 mg Avonex IM QW Lisinopril 10 mg po QD Advair 250/50 inh BID Omeprazole 20 mg po QD Ambien 10 mg po PRN Crestor 10mg QD
|
11 | $316.00 | |
| 67555 | Multiple Sclerosis | 1.0 ML | Caucasian African American Other | 41 | Female | United States (US) |
Doxycycline Spironolactone
|
15 | $316.00 | |
| 67448 | Multiple Sclerosis | 1.0 ML | Caucasian | 55 | Female | United States (US) |
HTZ 25mg daily, Ampyra, Brupropion 100mg b.i.d., Duloxetine 60mg daily, Baclofen 20mg 2-3 tabs at bedtime, Vit D2 50000 iu, fish oil, vit B12 1000mg/day, Kesimpta injections Q1M Baclofen 40 mg po QD HCTZ 12.5 mg po QD Cymbalta 60mg po QD Ampyra (generic) 10mg QD Wellbutrin 100mg BID Allergy pill (allergra) QD 5000IUD Vitamin D QD Vitamin B12 1000mcg QD
|
13 | $316.00 | |
| 67536 | Multiple Sclerosis | 1.0 ML | Hispanic/Latino | 41 | Male | United States (US) |
6/18/25- Baclofen 20mg 3× a day, tizanidine 4mg twice a daya Baclofen 20mg TID Tizanidine 5mg QD Zyrtec 10 mg QD Atorvastatin Fluoxetine
|
13 | $316.00 |
Multiple Sclerosis Plasma | High-Quality Human Plasma from Multiple Sclerosis Donors
Multiple Sclerosis Plasma is collected from donors clinically diagnosed with multiple sclerosis (MS) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on understanding disease activity, inflammation, and neurodegeneration. Bulk plasma is available.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed MS donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified MS diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional Multiple Sclerosis-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Multiple Sclerosis plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Multiple Sclerosis Publications
Plasma
Frequently Asked Questions
1 Answer
YES – Comprehensive medical records are available and may contain information regarding autoantibody status.
1 Answer
YES – Sanguine offers both inventory for select conditions, as well as, prospective collection. For inventory visit https://sanguinebio.com/products/plasma/?pro_inventory=inventory.
1 Answer
We never thaw our plasma samples before shipping.
1 Answer
Our standard aliquot size for plasma is 1 mL but we have bulk plasma (50 to 150 mL) available for select conditions. https://sanguinebio.com/product/human-bulk-plasma/
1 Answer
YES – Sanguine bio provides “age-matched healthy controls” and longitudinal studies capabilities.
1 Answer
YES – custom age specifications available – The “Specify I/E Criteria” service allows you to define specific age ranges for donor selection.
1 Answer
Age ranges available – Donor metadata includes age specifications, and you can specify inclusion/exclusion criteria. For pediatric samples specifically, contact learnmore@sanguinebio.com.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.